- /
- Supported exchanges
- / US
- / FULC.NASDAQ
Fulcrum Therapeutics Inc (FULC NASDAQ) stock market data APIs
Fulcrum Therapeutics Inc Financial Data Overview
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta-thalassemia. The company also discovers programs for the treatment of diamond-blackfan anemia, Bone Marrow Failure Syndromes, novel fetal hemoglobin inducers, fibrotic disorders. It has licensce agreement with CAMP4 which includes certain small molecule compounds, composition of matter and method of use patent rights, and know-how to research, develop, manufacture, use, and commercialize. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Fulcrum Therapeutics Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Fulcrum Therapeutics Inc data using free add-ons & libraries
Get Fulcrum Therapeutics Inc Fundamental Data
Fulcrum Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -85 177 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Fulcrum Therapeutics Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-02-26
- EPS/Forecast: -0.3055
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fulcrum Therapeutics Inc News
New
Fulcrum (FULC) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATE Monday, April 27, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Alexander SapirChief Financial Officer — Alan MussoChief Medical Officer ...
Fulcrum Therapeutics Shares Climb After Q1 Earnings Outperform Expectations
medical research 16 ©Rawpixel Fulcrum Therapeutics Inc. (NASDAQ:FULC) moved higher in pre-market trading on Monday after reporting first-quarter results that topped analyst expectations. The clinic...
Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors
CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (NASDAQ: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules that impr...
Pre-Market Earnings Report for April 27, 2026 : VZ, DPZ, ARLP, LKFN, HBT, BFST, FULC, BMRC, NWFL
The following companies are expected to report earnings prior to market open on 04/27/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Verizon Communications Inc. (...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.